No Data
No Data
H.C. Wainwright Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $45
Oruka Therapeutics Price Target Maintained With a $45.00/Share by HC Wainwright & Co.
Oruka Therapeutics Analyst Ratings
Jefferies Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $40
Oruka Therapeutics' Promising Long-Term Strategy and Advancements in Psoriasis Treatments Drive Buy Rating
Oruka Therapeutics to Present at Piper Sandler's 36th Annual Healthcare Conference
No Data
No Data
Stock_Drift : It’s not allowed north of the Mason Dixon line. Same with sugar in tea and Waffle Houses.
Stock_Drift : And I’m just kidding around.
MARKET-TEST-DUMMY OP Stock_Drift : Damn, that stings a little.
MARKET-TEST-DUMMY OP Stock_Drift : Absolutely! Enjoy it!
Stock_Drift MARKET-TEST-DUMMY OP : Just fun banter, I love the south, except Georgia.
View more comments...